Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-14 Purchase |
2022-11-16 4:58 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
16,053 | $3.0934 | $49,659 | 24,238 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-31 Tax Withholding |
2024-01-03 7:34 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
4,578 | $0.3402 | 234,477 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 7:34 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
11,188 | $0 | 234,477 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 7:33 pm |
N/A 2033-12-31 |
Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-30 Tax Withholding |
2023-10-03 7:37 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
7,172 | $0.6199 | 4,659,850 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:37 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
24,474 | $0 | 4,659,850 (Direct) |
View |
| 2023-09-30 Tax Withholding |
2023-10-03 7:36 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
3,444 | $0.6199 | 143,499 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:36 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
9,956 | $0 | 143,499 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:35 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,533 | $0 | 75,263 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:34 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,533 | $0 | 3,086,257 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:32 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,533 | $0 | 4,513,803 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:31 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,533 | $0 | 26,863 (Direct) |
View |
| 2023-09-30 Tax Withholding |
2023-10-03 7:30 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
2,624 | $0.6199 | 146,043 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:30 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,953 | $0 | 146,043 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-03 6:51 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,057 | $0.855 | 148,667 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:51 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
13,841 | $0 | 148,667 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:50 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,534 | $0 | 26,863 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:49 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,534 | $0 | 4,513,803 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:49 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,534 | $0 | 3,086,257 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:46 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,534 | $0 | 75,263 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-03 6:46 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
5,104 | $0.855 | 146,943 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:46 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
14,846 | $0 | 146,943 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-03 6:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
10,269 | $0.855 | 4,667,022 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
35,039 | $0 | 4,667,022 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:21 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,533 | $0 | 75,263 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:20 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,533 | $0 | 3,086,257 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:19 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,533 | $0 | 4,513,803 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:18 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,533 | $0 | 26,863 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,286 | $1.39 | 4,677,291 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
13,911 | $0 | 4,677,291 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:16 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
1,842 | $1.39 | 152,047 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:16 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
5,067 | $0 | 152,047 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,154 | $1.39 | 74,490 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,063 | $0 | 74,490 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:51 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
24,063 | $0 | 24,063 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:50 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | Brown Michael J Director |
24,063 | $0 | 24,063 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:49 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
390,851 | $0 | 548,746 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:47 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
24,063 | $0 | 24,063 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:45 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
180,922 | $0 | 238,070 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:44 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
180,922 | $0 | 229,672 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:43 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
24,063 | $0 | 24,063 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 4:11 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,859 | $0 | 16,730 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 4:10 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,859 | $0 | 4,503,670 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 4:09 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,859 | $0 | 3,076,124 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 4:08 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,859 | $0 | 65,130 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-03 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,406 | $2.37 | 75,644 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,062 | $0 | 75,644 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-03 4:03 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
2,569 | $2.37 | 75,655 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 4:03 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
6,297 | $0 | 75,655 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-03 3:59 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
7,141 | $2.37 | 8,790,505 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 3:59 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
20,635 | $0 | 8,790,505 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-03 3:58 pm |
N/A 2031-12-31 |
Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-03 7:59 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
1,753 | $1.52 | 78,224 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:59 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
5,066 | $0 | 78,224 (Direct) |
View |